Cerus (CERS)
(Delayed Data from NSDQ)
$2.11 USD
+0.24 (12.83%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $2.11 0.00 (0.00%) 6:20 PM ET
4-Sell of 5 4
D Value C Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CERS 2.11 +0.24(12.83%)
Will CERS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CERS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CERS
Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates
ResMed (RMD) Beats Q1 Earnings and Revenue Estimates
CERS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cerus (CERS) Reports Q2 Loss, Lags Revenue Estimates
Cerus (CERS) Reports Q1 Loss, Lags Revenue Estimates
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates
Other News for CERS
Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
Cerus announces symposium, abstracts as ISBT
Filtronic reports revenue growth after strong demand in key markets
Cerus Corporation Celebrates World Blood Donor Day 2024